| Vial description: |
MOR1, Mu-type opioid receptor |
| Category: |
primary antibody |
| Raised in: |
Rabbit |
| Clone: |
1 vial |
| Form: |
Affinity Purified |
| Reactivity: |
Mouse, Rat, Human |
| Purity: |
purified |
| Molecular weight: |
in kDa |
| Source: |
mammalian |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
P35372 |
| Application: |
Western Blot, ELISA |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Gene target: |
OPRM1 |
| Short name: |
anti-OPRM1 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, Antibody |
| Alternative name: |
mu 1 (Antibody to), antibody to-opioid receptor |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
Cell surfaces, LMOR and M-OR-1 and MOP and MOR and MOR1 and OPRM, OPRM1 and IDBG-635007 and ENSBTAG00000019719 and 281958, OPRM1 and IDBG-98194 and ENSG00000112038 and 4988, Oprm1 and IDBG-130147 and ENSMUSG00000000766 and 18390, coupled to cyclic nucleotide second messenger and biological process this GO :0007191 and adenylate cyclase-activating dopamine receptor signaling pathway and biological process this GO :0007193 and adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway and biological process this GO :0007194 and negative regulation of adenylate cyclase activity and biological process this GO :0007200 and phospholipase C-activating G-protein coupled receptor signaling pathway and biological process this GO :0007204 and positive regulation of cytosolic calcium ion concentration and biological process this GO :0007218 and neuropeptide signaling pathway and biological process this GO :0007600 and sensory perception and biological process this GO :0007626 and locomotory behavior and biological process this GO :0008285 and negative regulation of cell proliferation and biological process this GO :0016020 and membrane and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0019233 and sensory perception of pain and biological process this GO :0019904 and protein domain specific binding and molecular function this GO :0030425 and dendrite and cellular component this GO :0031005 and filamin binding and molecular function this GO :0031635 and adenylate cyclase-inhibiting opioid receptor signaling pathway and biological process this GO :0031681 and G-protein beta-subunit binding and molecular function this GO :0032094 and response to food and biological process this GO :0032100 and positive regulation of appetite and biological process this GO :0032496 and response to lipopolysaccharide and biological process this GO :0032590 and dendrite membrane and cellular component this GO :0032839 and dendrite cytoplasm and cellular component this GO :0033554 and cellular response to stress and biological process this GO :0038003 and opioid receptor signaling pathway and biological process this GO :0038047 and morphine receptor activity and molecular function this GO :0042060 and wound healing and biological process this GO :0042220 and response to cocaine and biological process this GO :0042383 and sarcolemma and cellular component this GO :0043204 and perikaryon and cellular component this GO :0043278 and response to morphine and biological process this GO :0043950 and positive regulation of cAMP-mediated signaling and biological process this GO :0043951 and negative regulation of cAMP-mediated signaling and biological process this GO :0045019 and negative regulation of nitric oxide biosynthetic process and biological process this GO :0045121 and membrane raft and cellular component this GO :0045429 and positive regulation of nitric oxide biosynthetic process and biological process this GO :0048149 and behavioral response to ethanol and biological process this GO :0050769 and positive regulation of neurogenesis and biological process this GO :0051481 and negative regulation of cytosolic calcium ion concentration and biological process this GO :0051930 and regulation of sensory perception of pain and biological process this GO :0060079 and regulation of excitatory postsynaptic membrane potential and biological process this GO :0061358 and negative regulation of Wnt protein secretion and biological process this GO :0070374 and positive regulation of ERK1 and ERK2 cascade and biological process this GO :0070588 and calcium ion transmembrane transport and biological process this GO :0070848 and response to growth factor and biological process this GO :0071315 and cellular response to morphine and biological process this GO :2000310 and regulation of N-methyl-D-aspartate selective glutamate receptor activity and biological process, morphine receptor activity, mu 1, this GO :0001965 and G-protein alpha-subunit binding and molecular function this GO :0002438 and acute inflammatory response to antigenic stimulus and biological process this GO :0004930 and G-protein coupled receptor activity and molecular function this GO :0004979 and beta-endorphin receptor activity and molecular function this GO :0004985 and opioid receptor activity and molecular function this GO :0005245 and voltage-gated calcium channel activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0005783 and endoplasmic reticulum and cellular component this GO :0005794 and this GO lgi apparatus and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0005925 and focal adhesion and cellular component this GO :0007186 and G-protein coupled receptor signaling pathway and biological process this GO :0007187 and G-protein coupled receptor signaling pathway, this GO :0001965 : G-protein alpha-subunit binding, this GO :0001965 : G-protein alpha-subunit binding and also this GO :0004930 : G-protein coupled receptor activity and also this GO :0004979 : beta-endorphin receptor activity and also this GO :0004985 : opioid receptor activity and also this GO :0005245 : voltage-gated calcium channel activity and also this GO :0005515 : protein binding and also this GO :0019904 : protein domain specific binding and also this GO :0031005 : filamin binding and also this GO :0031681 : G-protein beta-subunit binding and also this GO :0038047 : morphine receptor activity, this GO :0004930 : G-protein coupled receptor activity, this GO :0004979 : beta-endorphin receptor activity, this GO :0004985 : opioid receptor activity, this GO :0005245 : voltage-gated calcium channel activity, this GO :0005515 : protein binding, this GO :0019904 : protein domain specific binding, this GO :0031005 : filamin binding, this GO :0031681 : G-protein beta-subunit binding, this GO :0038047 : morphine receptor activity, opioid receptor |
| Identity: |
8156 |
| Gene: |
OPRM1 |
More about : OPRM1 |
| Long gene name: |
opioid receptor mu 1 |
| Synonyms gene name: |
mu 1 , opioid receptor |
| Synonyms: |
MOR1 |
| Locus: |
6q25, 2 |
| Discovery year: |
1993-03-11 |
| GenBank acession: |
L29301 |
| Entrez gene record: |
4988 |
| RefSeq identity: |
NM_000914 |
| Classification: |
Opioid receptors |
| Havana BLAST/BLAT: |
OTTHUMG00000015870 |
| Locus Specific Databases: |
LRG_1007 |